Sept 2 (Reuters) - Broadwood Partners, the largest

shareholder of STAAR Surgical ( STAA ), said on Tuesday it

intended to vote against Alcon's proposed acquisition

of the company, saying the Swiss eye care group's offer did not

reflect STAAR's recent financial improvements.

The investment firm, which holds a 27.5% stake in STAAR,

said it was disappointed with STAAR's board of directors for

choosing to sell the company without a comprehensive sale

process, and urged it to reconsider its recommendation of the

offer.

It also raised concerns over the timing of the proposed deal

in relation to an upcoming clinical trial publication.